CPI-0209 monotherapy incohort of mCRPC patients,cohort of ovarian clear-cell carcinoma patients (with ARID1A mutations),cohort of endometrial carcinoma patients (with ARID1A mutation). This evidence concerns the gene ARID1A and endometrial carcinoma.